High | P28028 | Serine/threonine-protein kinase B-raf OS=Mus musculus OX=10090 GN=Braf PE=1 SV=3 | 0.003 | 3.544 | 1 | 1 | 1 | 1 | 804 | 88.7 | 7.65 | | | 1 | | | 1 | | 865868.4375 | 1233298.5 | | 1 | 1 | | cell differentiation;cell organization and biogenesis;metabolic process;regulation of biological process;response to stimulus;transport | cytoplasm;cytosol;membrane;mitochondrion;nucleus | catalytic activity;metal ion binding;nucleotide binding;protein binding;signal transducer activity | "Pf00069, Pf00130, Pf02196, Pf07714, Pf14531" | 109880 | ENSMUSG00000002413.15 | Braf | 6 | CREB phosphorylation through the activation of Ras; RAF activation; Interleukin-20 family signaling; MAP2K and MAPK activation; Spry regulation of FGF signaling; Negative feedback regulation of MAPK pathway | ErbB signaling pathway; FoxO signaling pathway; Acute myeloid leukemia; mTOR signaling pathway; Regulation of actin cytoskeleton; MAPK signaling pathway; Progesterone-mediated oocyte maturation; Focal adhesion; Insulin signaling pathway; Endometrial cancer; Long-term potentiation; Chemokine signaling pathway; Breast cancer; Melanoma; Non-small cell lung cancer; Dorso-ventral axis formation; Proteoglycans in cancer; Neurotrophin signaling pathway; Long-term depression; Rap1 signaling pathway; Pathways in cancer; Hepatitis C; Alcoholism; Pancreatic cancer; Thyroid cancer; cAMP signaling pathway; Vascular smooth muscle contraction; Renal cell carcinoma; Natural killer cell mediated cytotoxicity; Glioma; EGFR tyrosine kinase inhibitor resistance; Colorectal cancer; Chronic myeloid leukemia; Serotonergic synapse; Prostate cancer; Endocrine resistance; Bladder cancer | 0 |